SEC Form D · Amendment · filed November 19, 2019
Renibus Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Bhupinder J. Singh · Southlake, TXDirectorHenrik J. Rasmussen · Southlake, TXDirectorAlvaro Guillem · Dallas, TXExec · DirectorD. J. Keyser · Southlake, TXExec · DirectorDesmond E. Mitchell · Luxembourg, LuxembourgExec · DirectorDalton M. Dale · ST. PETERSBURG, FLDirectorAnderson Growth Partners, LLC · Birmingham, ALExec · DirectorBrian H. Schreiber · Washington, Washington, D.C.DirectorEric F. Rieders · Horsham, PADirectorRalph N. Cram · Northbrook, ILDirectorScott Poland · Culver City, CAExec · DirectorBrent Iloulian · Culver City, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗